Drug profile · INN
betamethasone
CELESTONE
betamethasone (CELESTONE) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
Drug details — betamethasone
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 1
- Programs
- 8
- Data quality
- 0.84
Quick answer
betamethasone (CELESTONE) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is betamethasone?
betamethasone (CELESTONE) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for betamethasone?
CELESTONE is a marketed brand name for betamethasone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of betamethasone?
betamethasone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.